Calcium Aluminosilicate: Clinical Trials

3 trials of Calcium Aluminosilicate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated, 1 unknown. 3 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Completed 1, Terminated 1, Unknown 1
Phase 11Unknown 1

Follow Calcium Aluminosilicate: new trials by email Literature Review of Calcium Aluminosilicate trials Research Report on Calcium Aluminosilicate

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer
CASAD - Diarrhea, Medullary Thyroid Cancer
Phase 1 / Phase 2UnknownSalient Pharmaceuticals Incorporated102012-11-012012-12-03
Proof-of-Concept, Calcium Aluminosilicate Anti-Diarrheal (CASAD) for Treatment of Clostridium Difficile Infection
Calcium Aluminosilicate Anti-Diarrheal (CASAD) - Diarrhoea, Clostridium Difficile
Phase 2TerminatedSalient Pharmaceuticals Incorporated22012-03-012013-03-08
Calcium Aluminosilicate Anti-Diarrheal in Treating and Preventing Diarrhea in Patients With Metastatic Colorectal Cancer Receiving Irinotecan
calcium aluminosilicate anti-diarrheal, placebo - Chemotherapeutic Agent Toxicity, Colorectal Cancer
Phase 2CompletedM.D. Anderson Cancer Center1002009-02-042020-12-02

Conditions studied

Diarrhea (3)  ·  Carcinoma, Medullary (1)  ·  Colonic Neoplasms (1)  ·  Colorectal Neoplasms (1)  ·  Infections (1)  ·  Rectal Neoplasms (1)  ·  Spasm (1)

Sponsors

Salient Pharmaceuticals Incorporated (2)  ·  M.D. Anderson Cancer Center (1)

Countries

United States (3)

Top investigators

Aarthi Narasimhan, MD (1)  ·  Brian K. Kee, MD (1)  ·  Michael J. Fisch, MD, MPH, FACP (1)